Legis Daily

Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023

USA118th CongressHR-3684| House 
| Updated: 5/25/2023
Dan Crenshaw

Dan Crenshaw

Republican Representative

Texas

Cosponsors (15)
Ryan K. Zinke (Republican)David J. Trone (Democratic)J. Luis Correa (Democratic)Ro Khanna (Democratic)Rudy Yakym (Republican)Morgan Luttrell (Republican)Nancy Mace (Republican)Laurel M. Lee (Republican)Alexandria Ocasio-Cortez (Democratic)Derrick Van Orden (Republican)Earl Blumenauer (Democratic)Matt Gaetz (Republican)Jared Moskowitz (Democratic)Jack Bergman (Republican)Bill Johnson (Republican)

Armed Services Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Douglas "Mike" Day Psychedelic Therapy to Save Lives Act of 2023 This bill requires the Department of Defense (DOD) to award grants to eligible entities to research the treatment of certain members of the Armed Forces through the use of specified psychedelic substances (e.g., MDMA). Specifically, the research must focus on members of the Armed Forces who are serving on active duty and have been diagnosed with post-traumatic stress, a traumatic brain injury, or chronic traumatic encephalopathy. Under the bill, eligible entities include federal or state government entities, academic institutions, and nonprofit entities.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 25, 2023
Introduced in House
May 25, 2023
Referred to the House Committee on Armed Services.
  • May 25, 2023
    Introduced in House


  • May 25, 2023
    Referred to the House Committee on Armed Services.

Armed Forces and National Security

Douglas Mike Day Psychedelic Therapy to Save Lives Act of 2023

USA118th CongressHR-3684| House 
| Updated: 5/25/2023
Douglas "Mike" Day Psychedelic Therapy to Save Lives Act of 2023 This bill requires the Department of Defense (DOD) to award grants to eligible entities to research the treatment of certain members of the Armed Forces through the use of specified psychedelic substances (e.g., MDMA). Specifically, the research must focus on members of the Armed Forces who are serving on active duty and have been diagnosed with post-traumatic stress, a traumatic brain injury, or chronic traumatic encephalopathy. Under the bill, eligible entities include federal or state government entities, academic institutions, and nonprofit entities.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 25, 2023
Introduced in House
May 25, 2023
Referred to the House Committee on Armed Services.
  • May 25, 2023
    Introduced in House


  • May 25, 2023
    Referred to the House Committee on Armed Services.
Dan Crenshaw

Dan Crenshaw

Republican Representative

Texas

Cosponsors (15)
Ryan K. Zinke (Republican)David J. Trone (Democratic)J. Luis Correa (Democratic)Ro Khanna (Democratic)Rudy Yakym (Republican)Morgan Luttrell (Republican)Nancy Mace (Republican)Laurel M. Lee (Republican)Alexandria Ocasio-Cortez (Democratic)Derrick Van Orden (Republican)Earl Blumenauer (Democratic)Matt Gaetz (Republican)Jared Moskowitz (Democratic)Jack Bergman (Republican)Bill Johnson (Republican)

Armed Services Committee

Armed Forces and National Security

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted